Beginning October of 2012, the Affordable Care Act added section 1886(q) to section 3025 of the Social Security Act establishing the Hospital Readmissions Reduction Program. This program requires CMS to reduce payments to IPPS hospitals with excess readmissions. Translation: heavy fines due to patient readmission equals loss in hospital revenue. That’s why Aeroflow Healthcare has announced the Ventilator Program to work with COPD patients at high-risk for readmission.
COPD ranks third highest among Medicare beneficiaries readmission-related expenses and the national readmission rate for COPD is over 22 percent. Aeroflow Healthcare offers in-home ventilation treatment to prevent readmissions based on CMS criteria and can help hospitals save millions of dollars in lost revenue.
The Trilogy ventilator by Philips Respironics is light, versatile and easy to use. It offers portable volume and pressure support with proven BIPAP technology. Therapy can be either invasive or non-invasive, and the machine is available for adult and pediatric use. The simplicity of Trilogy ventilators encourages patient continued use. Event logs allow doctors to track changes outside medical recommendation, patient use or abuse. COPD patients will appreciate reduced medical expenses by avoiding extended hospital stays and readmissions.
Aeroflow Healthcare values patient care. We are a privately owned company headquartered in the Southeast but offer services nationwide. If you would like to begin referring your COPD patients to Aeroflow Healthcare or would like more information about our Hospital Readmission Reduction Program, call (888) 345-1780 to schedule an in-office presentation.